Skip to main content
OpenTrials
Completed

NCT Number: NCT02748824

Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal

To assess the five-year incidence of AMD in a population from the central region of Portugal, previously phenotypically characterized.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Subjects who participated in the Epidemiologic Coimbra Eye Study (NCT01298674) between 2009 and 2013 will attend a single visit, after giving informed consent.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects who participated in the Epidemiologic Coimbra Eye Study (NCT01298674) and that were phenotyped;
  • Subjects capable of understanding the information about the study and to give their informed consent to enter the study;
  • Subjects willing and able to comply with the study procedures.

Exclusion criteria

  • Not applicable

Treatment and study plan

Primary outcomes

  1. Phenotypic classification of AMD in the five-year clinical visit. Comparison of this classification with the grading of 5 years ago.

    Time frame: 5 years

Secondary outcomes

  1. Risk factors: Demographic, Medical history, Ophthalmologic history, Family history of AMD, Systemic comorbidities and medication, Nutritional and Lifestyle habits. Signs of AMD on the multimodal evaluation.

    Time frame: 5 years

Sponsors and collaborators

Lead sponsor

Association for Innovation and Biomedical Research on Light and Image

Other

Registry information

Acronym: AMDIncidencePT

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Apr 22, 2016
Registry last updated
Nov 9, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.